MIR342 and non-Hodgkin lymphoma: Based on qRT-PCR of miR-342-3p in 79 NHL primary samples, in whom both DNA and RNA were available, expression of miR-342-3p was shown significantly lower in patients with EVL/MIR342 methylation than those without EVL/MIR342 methylation (P = 0.0443, Fig. 3b).